U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. Requesting a Co-sponsorship with CDER
  1. Center for Drug Evaluation and Research (CDER)

Requesting a Co-sponsorship with CDER

CDER is often asked to engage in co-sponsorships (such as conferences, meetings, symposia, webinars, and workshops) with non-federal organizations who have a shared mutual interest and can provide relevant expertise, benefitting both CDER and the outside organization.  

Requirements for CDER co-sponsorships

  • CDER must be listed in the title of the event.
  • The affected Office Director accepts or declines each co-sponsorship proposal, using specific criteria.
  • If accepted, each draft co-sponsorship agreement must be cleared by FDA Office of Chief Counsel, the Center Director, or designee, and the Director of the outside organization.

Why might a co-sponsorship request be denied?

  • If the organization requesting the co-sponsorship agreement is a prohibited source.
  • If there is a potential conflict of interest.
  • If the requesting organization does not have substantive expertise in the subject matter.
  • If CDER and the requesting organization do not have a mutual interest and benefit in the proposed co-sponsored event.
  • If the proposed co-sponsorship agreement will not advance CDER’s mission and priorities.
  • If the proposed event will not allow CDER an opportunity to deliver a message to an appropriate audience.
  • If CDER does not have the necessary resources or staff available.
  • If there is not enough time to professionally complete this co-sponsorship request. A minimum of nine months is preferred to plan a co-sponsored event, to allow adequate time to develop the co-sponsorship agreement; ensure adequate planning, speaker selection, and appropriate publicity for the event.
    • If there is not enough time or resources to engage in a co-sponsorship, consider submitting a CDER Speaker Request for a CDER staff member to speak, or participate in a panel discussion.
    • CDER Speaker Requests require prior clearance and are tracked.

Logistics and marketing requirements

  • CDER has input and review in the event planning, agenda, and speaker selection.
  • Use of the FDA or CDER logo by any organization(s) is not permitted unless specifically mentioned within the terms of the co-sponsored agreement.
  • CDER reviews and clears all publicity materials, including photos and quotes.
  • Co-sponsored events may not generate monetary profit for any of the organizations involved. Any fees charged to attendees of the co-sponsored event should be designed to contribute towards event-related expenses.
    • Transcripts and educational materials may be sold, at cost, to event participants.

Withdrawal criteria

  • If CDER’s requirements are not met by the organization, the co-sponsorship agreement will be terminated.

Questions?  

Contact CDERCosponsorships@fda.hhs.gov.

Related Information

Back to Top